• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    OmniAb, Inc. - Common Stock (NQ: OABI )

    4.815 +0.015 (+0.31%)
    Streaming Delayed Price Updated: 12:16 PM EDT, Jul 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 102,321
    Open 4.890
    Bid (Size) 4.810 (13)
    Ask (Size) 4.820 (4)
    Prev. Close 4.800
    Today's Range 4.760 - 4.960
    52wk Range 3.560 - 6.715
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    OmniAb to Report Second Quarter 2024 Financial Results on August 8
    From OmniAb, Inc.
    Via Business Wire
    OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
    From OmniAb, Inc.
    Via Business Wire

    Performance

    YTD
    -22.96%
    -22.96%
    1 Month
    +27.04%
    +27.04%
    3 Month
    +8.69%
    +8.69%
    6 Month
    -20.68%
    -20.68%
    1 Year
    -9.83%
    -9.83%

    More News

    Read More
    OmniAb to Participate in the Jefferies Global Healthcare Conference
    From OmniAb, Inc.
    Via Business Wire
    OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit
    From OmniAb, Inc.
    Via Business Wire
    Recap: OmniAb Q4 Earnings
    Via Benzinga
    Earnings Preview For OmniAb
    Via Benzinga
    OABI Stock Earnings: OmniAb Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
    From OmniAb, Inc.
    Via Business Wire
    OmniAb to Participate in Five Investor Conferences in May
    From OmniAb, Inc.
    Via Business Wire
    OmniAb to Report First Quarter 2024 Financial Results on May 9
    From OmniAb, Inc.
    Via Business Wire
    Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
    From OmniAb, Inc.
    Via Business Wire
    Earnings Scheduled For March 20, 2024
    Via Benzinga
    OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
    From OmniAb, Inc.
    Via Business Wire
    OmniAb to Participate in Two Investor Conferences in March
    From OmniAb, Inc.
    Via Business Wire
    Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight
    Via InvestorPlace
    OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference
    From OmniAb, Inc.
    Via Business Wire
    OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event
    From OmniAb, Inc.
    Via Business Wire
    OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
    From OmniAb, Inc.
    Via Business Wire
    OmniAb to Participate in Two Investor Conferences in November
    From OmniAb, Inc.
    Via Business Wire
    OmniAb Appoints Steve Love to its Board of Directors
    From OmniAb, Inc.
    Via Business Wire
    OmniAb Announces Agenda for its Research & Technology Virtual Event
    From OmniAb, Inc.
    Via Business Wire
    7 of the Best Cheap Stocks to Buy Under $5 in October 2023
    Via InvestorPlace
    OmniAb to Hold Research & Technology Virtual Event on November 9
    From OmniAb, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.